How is the ImmunityBio Inc today?

The ImmunityBio Inc today is trading in the down by -2.99% at 3.24.

How has ImmunityBio Inc performed historically?

The ImmunityBio Inc is currently trading down -2.99% on an intraday basis in the past week the index rose 10.58%. The index has been up 14.89% in the past quarter and fell -45.64% in the past year. You can view this in the overview section.

What is ImmunityBio Inc Annual Revenue?

ImmunityBio Inc Annual Revenue rose 2,270.58%, in the last year to $14.74 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is ImmunityBio Inc Annual Net Profit?

ImmunityBio Inc Annual Net Profit rose 29.09% in the last year to $413.56 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is ImmunityBio Inc Price to Earning Ratio?

ImmunityBio Inc Price to Earning Ratio is -6.99, which is negative.

What is ImmunityBio Inc Stock Price?

ImmunityBio Inc Stock Price fell 45.64% and underperformed its sector by 74.36% in the past year.

What is ImmunityBio Inc Quarterly Revenue?

ImmunityBio Inc Quarterly Revenue rose 41,192.5% YoY to $16.52 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is ImmunityBio Inc Quarterly Net profit?

ImmunityBio Inc Quarterly Net profit rose 3.33% YoY to $129.65 M. Its sector's average net profit growth YoY for the quarter was -239.1%.

What is ImmunityBio Inc Mutual Fund Holding?

ImmunityBio Inc Mutual Fund Holding increased by 0.02% in the last quarter to 6.84.

What is ImmunityBio Inc Interest Coverage Ratio?

ImmunityBio Inc Interest Coverage Ratio is -2.14, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is ImmunityBio Inc Institutional Holding?

ImmunityBio Inc Institutional Holding decreased by 0.43% in the last quarter to 9.25.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
IMMUNITYBIO INC

ImmunityBio Inc XNAS: IBRX

ImmunityBio Inc Live Share Price Today, Share Analysis and Chart

Name: ImmunityBio Inc: Is Infosys Ltd. worth buying?
Item: ImmunityBio Inc
Rating: 1.27925
Author: Trendlyne DVM scores

about

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...

3.24 -0.10 (-2.99%)

57.54% Fall from 52W High

8.6M

XNAS Volume

XNAS 11 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for ImmunityBio Inc is on 18 Jun 2025 for the purpose of ImmunityBio Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

2.0 / 100

Technically Neutral

49.2 / 100

1Yr Price target upside is 252%

5 analysts

ImmunityBio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ImmunityBio Inc Live Share Price Today, Share Analysis and Chart

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...

57.54% Fall from 52W High

SWOT Analysis

ImmunityBio Inc Live Price Chart

ImmunityBio Inc FAQ

How is ImmunityBio Inc today?

ImmunityBio Inc today is trading in the red, and is down by -2.99% at 3.24.

How has ImmunityBio Inc performed historically?

ImmunityBio Inc is currently trading down -2.99% on an intraday basis. In the past week the stock rose 10.58%. stock has been up 14.89% in the past quarter and fell -45.64% in the past year. You can view this in the overview section.